BRD4 and neoplasm: A study by Milner et al. found that BRD4 inhibition with the drug JQ1 led to decreased levels of the exhaustion markers TIM3+/PD1+ on intratumoral tumor antigen–specific CD8+ T cells that were adoptively transferred in the B16-GP33 model (39).